Aoxin Q & M Dental Group Limited (SGX:1D4)
Singapore · Delayed Price · Currency is SGD 0.2100
-0.0050 (-2.33%)
At close: Aug 25, 2026
Aoxin Q & M Dental Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 160.59 | 171.05 | 177.49 | 177.26 | 139.72 | 160.18 |
Other Revenue | 4.75 | 4.73 | 2.07 | 0.95 | 0.53 | 0.21 |
| 165.34 | 175.78 | 179.56 | 178.2 | 140.25 | 160.39 | |
Revenue Growth | -10.29% | -2.10% | 0.76% | 27.06% | -12.56% | 20.12% |
Cost of Revenue | 128.65 | 132.51 | 137.68 | 135.48 | 117.96 | 129.4 |
Gross Profit | 36.69 | 43.27 | 41.88 | 42.73 | 22.29 | 30.99 |
Selling, General & Admin | 2.79 | 2.4 | 2.13 | 1.98 | 2.19 | 2.26 |
Other Operating Expenses | 12.8 | 14.52 | 15.72 | 18.49 | 13.88 | 18.4 |
Operating Expenses | 29.21 | 32.21 | 32.87 | 38.61 | 34.11 | 38.56 |
Operating Income | 7.48 | 11.07 | 9.01 | 4.11 | -11.82 | -7.57 |
Interest Expense | -0.8 | -0.97 | -1.49 | -1.8 | -2.44 | -3.12 |
Interest & Investment Income | 0.54 | 0.25 | 0.12 | 0.14 | 0.1 | 0.1 |
Earnings From Equity Investments | -0.43 | -0.03 | -14.24 | 1.06 | 1.72 | 1.27 |
Currency Exchange Gain (Loss) | 1.44 | -0.4 | 0.04 | -1.04 | -1.58 | 0.81 |
Other Non Operating Income (Expenses) | -0.59 | -1.08 | 0.12 | 0.29 | 1.34 | 1.77 |
EBT Excluding Unusual Items | 7.63 | 8.84 | -6.44 | 2.76 | -12.67 | -6.74 |
Gain (Loss) on Sale of Assets | -0.1 | -0.1 | - | - | - | - |
Asset Writedown | -1.49 | -0.07 | -0.11 | -0.03 | 0.03 | -0.06 |
Other Unusual Items | -0.18 | -0.28 | -0.06 | -46.87 | -60.32 | -0.03 |
Pretax Income | 5.86 | 8.4 | -6.57 | -44.14 | -72.96 | -6.83 |
Income Tax Expense | 1.47 | 1.46 | 1.43 | 3.16 | -5.29 | 0.49 |
Earnings From Continuing Operations | 4.39 | 6.93 | -8 | -47.3 | -67.68 | -7.33 |
Net Income to Company | 4.39 | 6.93 | -8 | -47.3 | -67.68 | -7.33 |
Minority Interest in Earnings | 0.2 | 0.04 | -0 | - | 0 | - |
Net Income | 4.59 | 6.97 | -8 | -47.3 | -67.67 | -7.33 |
Net Income to Common | 4.59 | 6.97 | -8 | -47.3 | -67.67 | -7.33 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 812 | 535 | 511 | 511 | 511 | 403 |
Shares Outstanding (Diluted) | 812 | 535 | 511 | 511 | 511 | 403 |
Shares Change | 58.77% | 4.71% | 0.00% | 0.09% | 26.80% | 5.57% |
EPS (Basic) | 0.01 | 0.01 | -0.02 | -0.09 | -0.13 | -0.02 |
EPS (Diluted) | 0.01 | 0.01 | -0.02 | -0.09 | -0.13 | -0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3.2 | 1.93 | 28.1 | 14 | 12.02 | -5.28 |
Free Cash Flow Per Share | 0.00 | 0.00 | 0.06 | 0.03 | 0.02 | -0.01 |
Gross Margin | 22.19% | 24.62% | 23.32% | 23.98% | 15.89% | 19.32% |
Operating Margin | 4.52% | 6.30% | 5.02% | 2.31% | -8.43% | -4.72% |
Profit Margin | 2.77% | 3.97% | -4.45% | -26.54% | -48.25% | -4.57% |
Free Cash Flow Margin | 1.93% | 1.10% | 15.65% | 7.86% | 8.57% | -3.29% |
EBITDA | 15.35 | 19.38 | 17.19 | 14.18 | -0.93 | 2.94 |
EBITDA Margin | 9.29% | 11.02% | 9.57% | 7.96% | -0.66% | 1.83% |
D&A For EBITDA | 7.87 | 8.31 | 8.18 | 10.07 | 10.89 | 10.51 |
EBIT | 7.48 | 11.07 | 9.01 | 4.11 | -11.82 | -7.57 |
EBIT Margin | 4.52% | 6.30% | 5.02% | 2.31% | -8.43% | -4.72% |
Effective Tax Rate | 25.12% | 17.41% | - | - | - | - |